Vector Science and Whoopi Wellness Collaborate on Peptide-Based Products for Women's Wellness
Vector Science and Therapeutics Corp. has invested in Whoopi Wellness, Inc., initiating a collaboration to develop peptide-based products for women's wellness. The partnership combines Vector's peptide manufacturing expertise with Whoopi Wellness's consumer brand and product lines.
Mequon, Wisconsin – Vector Science and Therapeutics Corp. (TSXV: PAIN) announced a strategic collaboration with Whoopi Wellness, Inc., a subsidiary of WhoopFam LLC co-founded by Whoopi Goldberg. The partnership includes an investment by Vector Science in Whoopi Wellness through a Simple Agreement for Future Equity (SAFE).
The collaboration aims to develop peptide-based products specifically for women's wellness. Vector Science will leverage its expertise in formulating and manufacturing high-purity peptides, adhering to stringent quality standards. The company's intellectual property includes pending patent applications for novel peptide delivery systems, addressing challenges related to the stability of peptides in consumer products.
This alliance seeks to merge Vector Science's advanced peptide delivery technology and manufacturing capabilities with Whoopi Wellness's established consumer brand and focus on personal care and wellness. Vector Science highlights its ability to create stable peptide formulations in liquid and gel formats, suitable for consumer applications.
"This relationship gives Vector early exposure to a company working in an area adjacent to our own. Women's health and the use of peptides are important areas of innovation," said Bill Jackson, CEO of Vector Science and Therapeutics. "We look forward to helping bring Whoopi Wellness products to market and supporting the company's mission to improve women's wellness."
The companies plan to utilize Vector Science's formulation knowledge to create potent and shelf-stable products, expanding Whoopi Wellness's portfolio with science-backed offerings.